Hyphens Pharma profit dives 44% in 2025 despite record 40.7% gross margins

Net profit fell to $6.1m in 2025 as higher costs and inventory write-offs offset proprietary brand growth.

Hyphens Pharma International Limited posted a net profit of $6.1m for the year ended 31 December 2025, down 44% from $10.9m in FY2024.

Basic earnings per share fell to 1.89 Singapore cents from 3.30 cents a year earlier, according to the company’s FY2025 financial statements.

Revenue declined 9.2% to $177.4m, as lower sales from the Pharmaceutical and Medical Aesthetics segment and the Digital Platform and e-Pharmacy segment outweighed a 33.1% increase in Proprietary Brands revenue to $36.7m.

Gross profit rose 3.8% to $72.2m, with the gross margin improving to 40.7% from 35.6%, reflecting higher-margin products in the company’s portfolio.

Hyphens Pharma said that despite challenges including foreign exchange volatility, elevated operating costs, and inventory write-offs, its diversified business model across three segments, namely Pharmaceutical and Medical Aesthetics, Proprietary Brands, and Digital Platform and e-Pharmacy, provides resilience.

Follow the link for more news on

Financial Statements

The people you want to reach are already in this room.

Every quarter, SBR lands on the desks of the founders, CFOs, and directors running Asia's most consequential companies. Every day, they open our newsletter and read our website. It's a room that took twenty years to build — and it's the one most of our partners are trying to get into.

The good news is that the door is open. We work with companies on thought leadership articles, sponsored content, industry summits across Southeast Asia, regional awards programmes, podcasts, and media placements in print and digital. The shape of the right partnership depends on what you're trying to do, which is why we'd rather start with a conversation than send a rate card.

If you have something this room should know about, tell us. We'll tell you honestly whether we can help, and how.

No rate cards until we understand the brief. It's a better use of everyone's time.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia